血管衰老驱动的勃起功能障碍:病理生理机制和新兴疗法 - - 一篇叙述性综述
Ke Zhong1, Huifang Hu1, Liang Xiao2
1Department of Urology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.
Translational andrology and urology
|January 12, 2026
概括
与年龄相关的勃起功能障碍 (ED) 与血管衰老有关. 针对内皮功能,干细胞和纳米技术的新疗法比目前对这种血管健康指标的治疗方法更有希望.
科学领域:
- 老年学是指老年学的学科.
- 血管生物学 血管生物学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 与年龄相关的勃起功能障碍 (ED) 是与血管衰老相关的重大健康问题,其特点是内皮功能障碍和血管光滑肌肉变化.
- 老年男性的ED与全身血管病理有关,作为整体血管健康的早期预警信号.
研究的目的:
- 在老年男性中探索与年龄相关的ED的病理生理机制.
- 为诊断和开发新型针对性治疗与年龄相关的ED提供新的方向.
主要方法:
- 从2000年到2025年进行了全面的文献综述.
- 包括PubMed,Web of Science和Embase在内的搜索使用了与勃起功能障碍,衰老,血管内皮和血管光滑肌相关的关键词.
- 优先考虑的是对病理生理学或新型治疗方法的高质量的临床和临床前研究.
主要成果:
- 与年龄相关的ED的主要贡献者包括氧化生物可用性降低,内皮氧化应激,炎症,光滑肌肉含量减少和动脉硬性增加.
- 代谢障碍,慢性炎症,氧化压力和荷尔蒙失衡加速血管衰老,使ED成为系统性血管病理的早期指标.
- 目前的治疗方法,如PDE5抑制剂和丸激素提供症状缓解,但有局限性;新兴的干预措施是实验性的.
结论:
- 与年龄相关的ED是系统血管病理的表现,也是血管健康的早期预警信号.
- 目前对ED的治疗有局限性,这突出了需要先进的治疗策略.
- 未来有前途的方向包括增强内皮NO合成酶功能,干细胞疗法和用于ED治疗的纳米技术.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
547
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
547
Disorders of the Male Reproductive System
3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Hypertension II: Pathophysiology
770
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
770
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
Peripheral Artery Disease III: Interprofessional Care
232
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
232


